leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 12:35:26 - browse：95

Adam's take main illustration — Molly Ferguson/STAT

This week, a preview of the TUDCA study in ALS and thoughts on how it might impact Amylyx Pharmaceuticals. Also, I chatted with CRISPR Therapeutics CEO Sam Kulkarni about its new investor. Read to the end for some burning questions, random thoughts.

The next ALS data readout — overdue but important

A European academic consortium is expected to announce results soon from a clinical trial investigating the use of a widely available nutritional supplement called tauroursodeoxycholic acid, or TUDCA, in people living with ALS. The outcome of the TUDCA-ALS study could have implications for Amylyx Pharmaceuticals, because TUDCA is one of the two main ingredients in Relyvrio, the company’s approved drug for ALS.

In a recent interview at Amylyx’s Kendall Square headquarters, co-CEOs Justin Klee and Josh Cohen mostly downplayed the suggestion that results from the randomized, placebo-controlled TUDCA study might affect Relyvrio negatively, or even positively.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Palantir health business leans on meeting customers’ needs

WSS

NIH fellows want a pay raise. Will that mean less money for grants?

Trump used to be more articulate. What could explain the change?

It's time to get medical device identifiers over the finish line

Restaurant meals are packed with calories, and we still keep eating them

Election results set back Medicaid expansion plans

NFL doctors' conflicts of interest could endanger players, report says

Wikipedia

leisure time

The next ALS data readout — overdue but important

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

What to know about OceanGate, the company behind the missing Titanic submersible

Supreme Court strikes down use of affirmative action

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

The cancer drug shortage isn’t new — and neither are the solutions

Palantir health business leans on meeting customers’ needs

Psychedelics group wrestles with new pharma identity

Iowa House, Senate pass 6

ChatGPT in medicine: STAT answers readers' burning questions

Tuberculosis patients need more than just free medication

entertainment

Trump used to be more articulate. What could explain the change?

Election results set back Medicaid expansion plans

Palantir health business leans on meeting customers’ needs

Living with Fabry disease, a condition that causes chronic pain

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

New research casts further doubt on a common procedure used with IVF

hotspot

entertainment

entertainment

focus